Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

With Spiriva under pressure, Boehringer moves to bolster pipeline

Forges alliance with PureTech Health

- PMLiVE

Mereo’s shareholders back OncoMed takeover

Deal expected to go through next week

Lucid Group announces the appointment of new CFO

Lucid Group continues to build its infrastructure in line with its ambitious growth plans by appointing Michael Joyce as Chief Financial Officer (CFO).Michael has considerable experience as a CFO and...

Lucid Group Communications Limited

- PMLiVE

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality

How pharma is progressing their commitment in patient engagement

- PMLiVE

Q&A: Niels Lund

PME interviews Novo Nordisk's Vice President, Health Advocacy

- PMLiVE

Novartis makes case for gene therapy Zolgensma in SMA

New data revealed ahead of FDA review

- PMLiVE

Adding different perspectives to scientific communications at Porterhouse Medical

Porterhouse Medical Group is delighted to announce that, once again, we have strengthened our scientific services team – this time with three new associate medical writers who, with different scientific...

Porterhouse Medical Group

- PMLiVE

Stem cell transplant firms Kiadis and CytoSen join forces

Acquires an NK cell based platform with the deal

Roche Basel Switzerland

Hemlibra off to a flyer as Roche raises 2019 forecasts

Drug has made almost as much in this quarter as it did in 2018

- PMLiVE

Gilead drives NASH development with insitro collaboration

Announcement comes days after Novo Nordisk deal

- PMLiVE

Akcea steals march on Alnylam with NICE approval

Advantage to Tegsedi over Onpattro

- PMLiVE

Catalent preps for complex therapy boom with $1.2bn Paragon buy

Reflects growing investment in cell and gene therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links